Evaluating Capacitive and Resistive Energy Transfer Therapy Plus Exercise for Treating Lateral Epicondylitis in a Double-Blind, Sham-Controlled Clinical Trial

What this Trial Is About

Researchers are evaluating Capacitive and Resistive Energy Transfer TECAR therapy combined with exercise for patients suffering from lateral epicondylitis, a condition causing elbow pain. This prospective, randomized, double-blind, sham-controlled clinical trial aims to determine if adding TECAR therapy to a standardized exercise program improves pain relief, function, and clinical outcomes compared to exercise alone. Participants are randomly assigned to one of two groups the TECAR therapy plus exercise group or the sham TECAR therapy plus exercise group. Both groups follow a home exercise program including elbow and wrist range-of-motion, stretching, eccentric strengthening, and handgrip exercises performed three times daily. The TECAR group receives active TECAR therapy five times a week for two weeks, with each 15-minute session involving capacitive and resistive modes targeting different tissue depths. The sham group uses the same device and protocol but without therapeutic energy delivery. Participants will be assessed at baseline, immediately after treatment, and at one and two months post-treatment by a blinded evaluator. Assessments include pain levels using the Visual Analog Scale, pressure pain threshold, ultrasound imaging, handgrip strength, and patient-reported function scores. Adherence to exercises and splint use is monitored through weekly phone calls and daily logs. The total study duration per participant includes treatment over two weeks and follow-up visits up to two months.

Evaluation of the Effectiveness of Capacitive and Resistive Energy Transfer Therapy for Lateral Epicondylitis